| scholarly article | Q13442814 |
| P50 | author | Mijin Yun | Q61151102 |
| Jae-Ho Cheong | Q63644867 | ||
| Yong-Min Huh | Q63978764 | ||
| Seok-gu Kang | Q42788516 | ||
| P2093 | author name string | Ji-Hyun Lee | |
| Junseong Park | |||
| Eui Hyun Kim | |||
| Jong Hee Chang | |||
| Pilnam Kim | |||
| Sun Ho Kim | |||
| Jeong Yong Jeon | |||
| Junjeong Choi | |||
| Kyung-Sup Kim | |||
| Jin-Kyoung Shim | |||
| Ilkyoo Koh | |||
| Yoonjee Oh | |||
| P2860 | cites work | Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide | Q42794498 |
| Differential responses of tumors and normal brain to the combined treatment of 2-DG and radiation in glioablastoma | Q43222513 | ||
| Mechanisms of glucose transport at the blood-brain barrier: an in vitro study | Q43715225 | ||
| 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro | Q46630183 | ||
| Metformin and cancer stem cells: old drug, new targets. | Q52622589 | ||
| The mechanisms by which mild respiratory chain inhibitors inhibit hepatic gluconeogenesis | Q70622105 | ||
| The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells | Q95804869 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| Glycolysis inhibition for anticancer treatment | Q28256222 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma | Q29615607 | ||
| Mitochondria and cancer | Q29616610 | ||
| Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns. | Q30476738 | ||
| Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. | Q33877459 | ||
| Molecular targeting of glioblastoma: Drug discovery and therapies | Q33911283 | ||
| Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. | Q34007740 | ||
| Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. | Q34182185 | ||
| Cancer stem cells: an old idea--a paradigm shift | Q34495973 | ||
| Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers | Q35161318 | ||
| Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function | Q35223050 | ||
| Metabolic state of glioma stem cells and nontumorigenic cells | Q35229102 | ||
| Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect | Q35605096 | ||
| Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models | Q35613319 | ||
| Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis | Q36026661 | ||
| Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells | Q36213711 | ||
| Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. | Q36604614 | ||
| Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK. | Q36861418 | ||
| HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. | Q37015151 | ||
| Potential applications for biguanides in oncology | Q37123877 | ||
| Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. | Q37205539 | ||
| Glioma stem cells: turpis omen in nomen? (The evil in the name?). | Q38202702 | ||
| The role of cancer stem cells in glioblastoma | Q38272729 | ||
| Potential use of glioblastoma tumorsphere: clinical credentialing. | Q38335033 | ||
| Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions. | Q39176844 | ||
| Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis | Q40371829 | ||
| P433 | issue | 2 | |
| P921 | main subject | metformin | Q19484 |
| glioblastoma | Q282142 | ||
| P304 | page(s) | 197-207 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin | |
| P478 | volume | 19 |
| Q92442029 | 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents |
| Q58573420 | Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma |
| Q89960671 | Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma |
| Q90580382 | Glioblastoma Cellular Origin and the Firework Pattern of Cancer Genesis from the Subventricular Zone |
| Q30353578 | Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A). |
| Q58728819 | Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability |
| Q92733028 | Metformin as Potential Therapy for High-Grade Glioma |
| Q58698115 | Metformin as a Therapeutic Target in Endometrial Cancers |
| Q64236894 | Mitochondria-centric bioenergetic characteristics in cancer stem-like cells |
| Q57072227 | Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo |
| Q47222664 | Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres |
| Q47115276 | Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma |
| Q64098059 | Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity |
| Q64244912 | Targeting Glioblastoma Stem Cells with 2-Deoxy-D-Glucose (2-DG) Potentiates Radiation-Induced Unfolded Protein Response (UPR) |
Search more.